You nominated and our expert judging panels deliberated – and now, we proudly showcase this diversity of talent in The Pathologist’s 2020 Power List.
NAPPA, a novel profiling system for Crohn's disease, offers a new diagnostic test and more insight into the disease
Undiagnosed patients with iMCD may be helped by a new set of identification benchmarks
Standardization has a vital role in making sure tests stay accurate and reliable
Awareness of infectious disease disagnostics have increased with the prevalence of high-profile outbreaks
There may be a way to detect resistance to the emergency antibiotic colistin
Transcriptomic analysis may help predict the survival rate of Ebola patients
Is screening for herpes in asymptomatic people really worth the deficits?
Classification needs to adapt as the rest of science does, lest we stifle progress
FMF patients can remain undiagnosed for years, but a new diagnostic hopes to alleviate that
Could the solution for diagnostics and treatments for African sleeping sickness lie in camel urine?
Register to access our FREE online portfolio, request the magazine in print and
manage your preferences.